Literature DB >> 30212816

Correlations between the Recurrence Patterns and Sizes of Lateral Pelvic Lymph Nodes before and after Chemoradiotherapy in Patients with Lower Rectal Cancer.

Hiroshi Shiratori1, Kazushige Kawai2, Keisuke Hata2, Toshiaki Tanaka2, Takeshi Nishikawa2, Kazuhito Sasaki2, Manabu Kaneko2, Koji Murono2, Shigenobu Emoto2, Teppei Morikawa3, Masashi Fukayama3, Hiroaki Nozawa2.   

Abstract

OBJECTIVE: Factors that predict rectal cancer metastasis to the lungs remain undefined. We investigated whether the lateral pelvic lymph node (LPN) sizes before and after chemoradiotherapy (CRT) correlate with lung metastasis after surgery for lower rectal cancer.
METHODS: Two hundred and forty patients with lower rectal cancer who received preoperative CRT and curative surgery between 2003 and 2017 were examined. Computed tomography-measured LPN sizes before and after CRT were retrospectively determined by 1 colorectal surgeon who was blinded to the patients' clinical and pathological outcomes.
RESULTS: The 5-year cumulative lung metastasis rates were 15.2%. The mean LPN sizes in patients who developed lung metastasis were larger than those in patients who did not (pre-CRT: 8.7 vs. 6.3 mm, p = 0.003; post-CRT: 6.8 vs. 4.5 mm, p = 0.001). The cumulative lung metastasis rate in patients with large LPNs was higher than in those with small LPNs both before and after CRT. On multivariate analysis, lung metastasis was independently correlated with the LPN size only after CRT (hazard ratio [HR]: 5.58), together with the ypT stage (HR: 2.96) and the tumor location (HR: 0.38).
CONCLUSIONS: LPN size after CRT is strongly predictive of postoperative lung metastasis in patients with lower rectal cancer.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Chemoradiotherapy; Lateral pelvic lymph node; Liver metastasis; Lung metastasis; Rectal cancer

Mesh:

Year:  2018        PMID: 30212816     DOI: 10.1159/000492493

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  4 in total

1.  Effect of Simultaneous Integrated Boost Intensity Modulated Radiation Therapy (SIB-IMRT) and Non-Operative Strategy on Outcomes of Distal Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node.

Authors:  Shuai Li; Jianhao Geng; Lin Wang; Huajing Teng; Zhilong Wang; Xianggao Zhu; Yangzi Zhang; Hongzhi Wang; Yongheng Li; Yong Cai; Aiwen Wu; Weihu Wang
Journal:  Cancer Manag Res       Date:  2021-01-22       Impact factor: 3.989

2.  The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes.

Authors:  Elisa Meldolesi; Giuditta Chiloiro; Roberta Giannini; Roberta Menghi; Roberto Persiani; Barbara Corvari; Claudio Coco; Stefania Manfrida; Carlo Ratto; Viola De Luca; Luigi Sofo; Sara Reina; Antonio Crucitti; Valeria Masiello; Nicola Dinapoli; Vincenzo Valentini; Maria Antonietta Gambacorta
Journal:  Cancers (Basel)       Date:  2022-03-24       Impact factor: 6.639

3.  Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients With Clinically Positive Lateral Pelvic Lymph Node.

Authors:  Shuai Li; Yangzi Zhang; Yang Yu; Xianggao Zhu; Jianhao Geng; Huajing Teng; Zhilong Wang; Tingting Sun; Lin Wang; Hongzhi Wang; Yongheng Li; Aiwen Wu; Yong Cai; Weihu Wang
Journal:  Front Oncol       Date:  2021-02-22       Impact factor: 6.244

4.  A predictive model for early recurrence of colorectal-cancer liver metastases based on clinical parameters.

Authors:  Siqi Dai; Yao Ye; Xiangxing Kong; Jun Li; Kefeng Ding
Journal:  Gastroenterol Rep (Oxf)       Date:  2021-01-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.